Why aren’t there quality controls for antibody research?

Antibodies are not only important when you are sick but they are also essential tools in all domains of life science research. Assumed to specifically bind their target protein, antibodies are used to identify and quantify numerous research targets. Whole clinical trials and therapies are based on findings stemming from antibody usage. Yet these antibodies have recently been show to exhibit an insufficient specificity (and sometimes even specifically bind to the wrong protein!).

In this recent article for Massive Science, I explore the pitfalls of using poor-quality antibodies in research, consequences resulting from this as well as why we ended up with this situation in the first place.

Update: My article was republished by the American Society for Biochemistry and Molecular Biology (ASBMB) which shares my conviction that this is a crucial topics which requires our attention!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close